Office of Ronald Yanagihara — Gilroy, California

Office of Ronald Yanagihara is a clinical research site located in Gilroy, California, United States 95020.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Office of Ronald Yanagihara has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Non-Small Cell Lung.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Gilroy

Browse all research sites in California · View every site in Gilroy

• Columbia South Valley Hospital
• Saint Louise Regional Hospital Radiology Department (Radiology Only)
• Pfizer Investigational Site
• Research Site
• Care Access - Gilroy
• ImClone Investigational Site
• South Valley Medical Plaza
• Kaiser Permanente Medical Center Lab Drawing Station
• Global Cancer Research Institute, Inc.
• Medical Oncology/Hematology
• Global Cancer Research Institute (GCRI), Inc
• Ronald H. Yanagihara

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Office of Ronald Yanagihara?

Office of Ronald Yanagihara has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Office of Ronald Yanagihara conducted?

Office of Ronald Yanagihara has 1 clinical trials on record. Their work covers Carcinoma, Non-Small Cell Lung.

Is Office of Ronald Yanagihara accredited by Crixeo Clinical Trials?

Office of Ronald Yanagihara has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Office of Ronald Yanagihara?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.